🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Carboplatin kills cancer cells mainly through induction of DNA damage (drug...
Status
Terminated
Location
University of California Los Angeles
Start Date
2010-12
Trial ID
NCT01261299
Treatments Being Tested
This is a global, multicenter, randomized, open-label, Phase 2/3 study of D...
Status
Recruiting
Location
Research Site
Start Date
2025-09-26
Trial ID
NCT07129993
Treatments Being Tested
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
This is a study to look at whether the presence of circulating tumour DNA (...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2022-03-28
Trial ID
NCT04966663
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
Cisplatin and Etoposide is the standard of care in NEC originating from the...
Status
Unknown
Location
S.C. Oncologia - Policlinico
Start Date
2015-05
Trial ID
NCT02687958
Treatments Being Tested
Quisinostat besides its own efficacy, which can potentially lead to better ...
Status
Completed
Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Start Date
2013-08
Trial ID
NCT02728492
Treatments Being Tested
This study was designed to evaluate the efficacy and safety of 7MW3711 in c...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2026-02-11
Trial ID
NCT07466160
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of divaras...
Status
Recruiting
Location
Alaska Oncology and Hematology
Start Date
2025-10-24
Trial ID
NCT06793215
Treatments Being Tested